Domestic pharma firms to roll out low-cost Empagliflozin for diabetes care: Report
Currently priced at Rs 60 per tablet, Empagliflozin’s generic versions will be available for as low as Rs 9-Rs 14 per tablet, significantly reducing costs for millions of patients, states the report.
Ahead of full-fledged bilateral trade agreement, India and US aim for preliminary pact: Report
New Delhi wants to finalise the contour of the trade pact based on the structure in the trade pacts with other nations such as Australia, UAE.